In addition, Yang et al. revealed that antidiabetic metformin acts as an anti-BC agent by reducing the protein stability of SLC7A11 of system xc-, increasing intracellular Fe2+ and lipid ROS levels [53]. The gene discussed is SLC7A11; the disease is breast cancer.